Final designs for UK Gov-backed facility 'weeks away' says Cell Therapy Catapult CEO
The CEO of Cell Therapy Catapult says technical designs for the new UK biomanufacturing centre will be completed in the next few weeks.
Archives for October 12, 2015
Dispatches from CPhI 2015
Ex-FDA inspector: How to avoid 483 observations during your next facility audit
Want to pass an FDA inspection? Do not answer back, do not volunteer information and do not sign anything, says an ex-auditor and regulatory consultant.
DSM's Nutritional Products team in Spain to sell vitamin APIs to drugmakers
DSM may have narrowed the focus of its pharmaceutical business in recent years, but the Netherlands-based supplier is still trying to win drug industry customers at a trade show in Spain.
CPhI Worldwide 2015
If you want new excipients, regulate them, says BASF
A BASF expert is calling for an independent review body for new excipients to reassure wary drugmakers of their quality.
It's not easy being green, but biotechs should consider it according to Piramal
Pharma and biotech firms not using ‘green chemistry’ to make their products incur higher costs and risk losing market share according to Piramal.
Dispatches from CPhI
INN guidance leaves FDA in catch-22 over awaited interchangeability rules, experts
Eagerly awaited interchangeability guidance will be at odds with the US FDA’s recent guidance on naming biological products using a four-letter suffix according to a panel of biosimilar experts.